McKesson Corporation Stock price

Equities

MCK

US58155Q1031

Pharmaceuticals

Real-time Estimate Cboe BZX 02:48:04 2024-03-28 pm EDT 5-day change 1st Jan Change
535.4 USD -0.71% Intraday chart for McKesson Corporation +0.32% +15.75%
Sales 2024 * 312B Sales 2025 * 336B Capitalization 70.86B
Net income 2024 * 3.03B Net income 2025 * 3.52B EV / Sales 2024 * 0.23 x
Net Debt 2024 * 1.75B Net Debt 2025 * 375M EV / Sales 2025 * 0.21 x
P/E ratio 2024 *
24.5 x
P/E ratio 2025 *
19.5 x
Employees 48,000
Yield 2024 *
0.45%
Yield 2025 *
0.5%
Free-Float 46.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.59%
1 week+1.60%
Current month+3.42%
1 month+3.91%
3 months+17.87%
6 months+21.35%
Current year+16.48%
More quotes
1 week
529.99
Extreme 529.99
539.99
1 month
517.92
Extreme 517.92
539.99
Current year
462.70
Extreme 462.7
539.99
1 year
352.34
Extreme 352.34
539.99
3 years
180.42
Extreme 180.415
539.99
5 years
111.71
Extreme 111.71
539.99
10 years
106.11
Extreme 106.11
539.99
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 11-12-31
Director of Finance/CFO 55 18-01-26
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Chairman 73 14-10-19
Director/Board Member 62 22-03-31
Director/Board Member 66 22-01-12
More insiders
Date Price Change Volume
24-03-28 535.9 -0.63% 137 040
24-03-27 539.3 +0.59% 426,489
24-03-26 536.1 +0.66% 538,664
24-03-25 532.6 -0.00% 310,513
24-03-22 532.6 -0.30% 426,685

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (80.4%); - distribution of medical and surgical products (4.4%); - other (1.5%): primarily technology services and software sales. The remaining sales (13.8%) are from international activities.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
539.3 USD
Average target price
547.4 USD
Spread / Average Target
+1.51%
Consensus
  1. Stock
  2. Equities
  3. Stock McKesson Corporation - Nyse